What is Medical Developments International Quick Ratio?
Medical Developments InternationalFRA:M5D +1.55%32 Quick Ratio is 4.54 as of Dec. 2025, which is 68% above its 10-year median of 2.71. GuruFocus rates FRA:M5D with a GF Score™ of 32/100 and a GF Value™ of €0.35 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 997 Drug Manufacturers companies, Medical Developments International ranks better than 87.86% on this metric.
FRA:M5D'
s Quick Ratio Range Over the Past 10 Years
Min: 0.91 Med: 2.71 Max: 5.99
Current: 4.54
During the past 13 years, Medical Developments International's highest Quick Ratio was 5.99. The lowest was 0.91. And the median was 2.71.
FRA:M5D's Quick Ratio is ranked better than 87.86% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs FRA:M5D: 4.54
Medical Developments International (FRA:M5D) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Medical Developments International Quick Ratio Related Terms
Medical Developments International Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Developments International Quick Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Developments International Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Medical Developments International's Quick Ratio falls into.
Medical Developments International Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Developments International (FRA:M5D) has a Quick Ratio of 4.54 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Medical Developments International and its competitors. This is 68% above median its historical median of 2.71. Over the past decade, Medical Developments International's Quick Ratio has ranged from 0.91 to 5.99. According to the industry distribution chart, Medical Developments International ranks #121 out of 997 companies in the Drug Manufacturers industry, placing it in the top 12.1%.
Is Medical Developments International's Quick Ratio too high?
Medical Developments International's current Quick Ratio of 4.54 is 68% above median its 10-year median of 2.71. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 5.99. The Drug Manufacturers industry median Quick Ratio is 1.45. Medical Developments International's value of 4.54 is 213.1% above this industry median. Based on the distribution chart, Medical Developments International ranks #121 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Medical Developments International has a GF Score™ of 32/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Quick Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Medical Developments International ranks #121 out of 997 companies for Quick Ratio. This places Medical Developments International in the top 12% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Medical Developments International's value of 4.54 is 213.1% above this benchmark. Historically, Medical Developments International's own Quick Ratio has ranged from 0.91 to 5.99 over the past decade. While the company's 10-year median is 2.71 vs. the industry median of 1.45, Medical Developments International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Developments International's current Quick Ratio of 4.54 is 213.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Medical Developments International and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Developments International's current Quick Ratio is 4.54, which is 68% above median its own 10-year median of 2.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (FRA:M5D) is currently considered Significantly Undervalued. The stock's GF Value™ is €0.35, compared to a current price of €0.20 — trading 43.7% below its estimated fair value. The current Quick Ratio is 4.54, which is 68% above median its 10-year median of 2.71 and 213.1% above the Drug Manufacturers industry median of 1.45. Medical Developments International's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Medical Developments International (FRA:M5D), the current Quick Ratio is 4.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Developments International (FRA:M5D) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued.
The current stock price of €0.20 is trading 43.7% below its estimated GF Value™ of €0.35.
GuruFocus considers Medical Developments International to be Significantly Undervalued.
Key valuation signals for FRA:M5D:
Quick Ratio: 4.54 (68% above median its 10-year median of 2.71)
GF Value™: €0.35 vs. price of €0.20 (43.7% below fair value)
Industry Position: 213.1% above the Drug Manufacturers median (#121 of 997)
No single metric tells the full story. See the FRA:M5D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Developments International Business Description
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
32GF Score
Get the complete analysis for FRA:M5D
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M5D has been successfully added to your 
